Detalhe da pesquisa
1.
Rucaparib or Physician's Choice in Metastatic Prostate Cancer.
N Engl J Med
; 388(8): 719-732, 2023 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36795891
2.
Management of urothelial cancer in patients with chronic kidney disease receiving platinum-based chemotherapy.
Future Oncol
; 2024 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38706176
3.
Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis.
Lancet Oncol
; 24(6): 669-681, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37187202
4.
The role of cytoreductive nephrectomy and systemic therapy in the management of tumour thrombus in patients with metastatic renal cell carcinoma.
Br J Cancer
; 128(10): 1888-1896, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36859686
5.
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma.
N Engl J Med
; 383(13): 1218-1230, 2020 09 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32945632
6.
Impact of Maximal Transurethral Resection on Pathological Outcomes at Cystectomy in a Large, Multi-institutional Cohort.
J Urol
; 209(5): 882-889, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36795962
7.
Identification of characteristics predictive of long-term survival with durvalumab or durvalumab plus tremelimumab in metastatic urothelial carcinoma.
BMC Cancer
; 23(1): 919, 2023 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37773115
8.
Symptom screening with Targeted Early Palliative care (STEP) versus usual care for patients with advanced cancer: a mixed methods study.
Support Care Cancer
; 31(7): 404, 2023 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37341839
9.
Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder Cancer.
J Urol
; 207(1): 70-76, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34445891
10.
Multicenter evaluation of neoadjuvant and induction gemcitabine-carboplatin versus gemcitabine-cisplatin followed by radical cystectomy for muscle-invasive bladder cancer.
World J Urol
; 40(11): 2707-2715, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36169695
11.
Targeting the FGFR Pathway in Urothelial Carcinoma: the Future Is Now.
Curr Treat Options Oncol
; 23(9): 1269-1287, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35962938
12.
Targeting FGFR3 alterations with adjuvant infigratinib in invasive urothelial carcinoma: the phase III PROOF 302 trial.
Future Oncol
; 18(21): 2599-2614, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35608106
13.
Plain language summary of results from the JAVELIN Bladder 100 study: avelumab maintenance treatment for advanced urothelial cancer.
Future Oncol
; 18(19): 2361-2371, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35416053
14.
The Rapidly Evolving Landscape of First-Line Targeted Therapy in Metastatic Urothelial Cancer: A Systematic Review.
Oncologist
; 26(8): e1381-e1394, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34028134
15.
Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma.
BJU Int
; 127(5): 528-537, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32981193
16.
Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer without hydronephrosis.
BJU Int
; 128(1): 79-87, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33152179
17.
Phase II Trial of Symptom Screening With Targeted Early Palliative Care for Patients With Advanced Cancer.
J Natl Compr Canc Netw
; 20(4): 361-370.e3, 2021 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34492632
18.
Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer.
World J Urol
; 39(12): 4345-4354, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34370078
19.
Impact of age at diagnosis of de novo metastatic prostate cancer on survival.
Cancer
; 126(5): 986-993, 2020 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31769876
20.
Patient-reported outcomes and inflammatory biomarkers in patients with locally advanced/metastatic urothelial carcinoma treated with durvalumab in phase 1/2 dose-escalation study 1108.
Cancer
; 126(2): 432-443, 2020 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31581306